2023. Curcumin for Aromatase Inhibitor-Induced Joint Pain in Breast Cancer Survivors - The CurPain Trial: A Randomized, Double-Blind, Phase III, Multicenter Clinical Trial. Principles and Practice of Clinical Research. 9, 2 (Sep. 2023). DOI:https://doi.org/10.21801/ppcrj.2023.92.10.